Merck, Ridgeback submit EUA application for their pill to treat COVID-19
Merck & Co. Inc.
MRK,
-1.60%
and Ridgeback Biotherapeutics said Monday that Merck has submitted an application for Emergency Use Authorization (EUA) with the Food and Drug Administration for molnupiravir, their oral antiviral medicine for the treatment…
